Trial Site Detail

 

Drug:
Nilotinib or Imatinib
Trial:
Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Oncologos del Occidente S.A.

     
Pareira ,
Colombia

 

Principal Investigator:
 Gustavo Rojas, MD
Contact:
 Paula Londono, MD +57-6-3310712 palodelosrios@gmail.com
Activation Status of this Site:
 Closed
Notes about this Site:
Oncologos del Occidente S.A. Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.